Publication:
Gemcitabine-associated reversible encephalopathy a case report

Simple item page
dc.contributor.authorsBerrak S.G., Soysal A., Türkkan E., Canpolat C.
dc.date.accessioned2022-03-28T14:51:21Z
dc.date.accessioned2026-01-10T18:35:07Z
dc.date.available2022-03-28T14:51:21Z
dc.date.issued2002
dc.description.abstractIn this report, we present a ten-year-old male patient with metastatic Ewing's sarcoma who developed encephalopathy after treatment with gemcitabine, and his rapid recovery after discontinuation of the drug.
dc.identifier.issn10191941
dc.identifier.urihttps://hdl.handle.net/11424/255662
dc.language.isoeng
dc.relation.ispartofMarmara Medical Journal
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectGemcitabine
dc.subjectNeurotoxicity
dc.subjectPediatric cancer
dc.titleGemcitabine-associated reversible encephalopathy a case report
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage182
oaire.citation.issue3
oaire.citation.startPage180
oaire.citation.titleMarmara Medical Journal
oaire.citation.volume15

Files

Collections

Araştırma Çıktıları